Sort   by:  
 Page size 
TranscriptomicsAspergillus fumigatus Af293 response to lactic acid bacteria antifungal activity
The effect of cell free supernatant from the antifungal strain Lactobacillus plantarum 16 on the growth of Aspergillus fumigatus Af293 was assessed. Transcriptome analysis of the genome was performed after ten minutes exposure to antifungal supernatant in order to determine the molecular targets inv...
ORGANISM(S): Aspergillus fumigatus 
2013-08-09 | E-MTAB-1701 | biostudies-arrayexpress
UnknownPharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.
Not available
S-EPMC5089614 | biostudies-literature
UnknownORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.
Not available
S-EPMC11396014 | biostudies-literature
UnknownPhase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.
Not available
S-EPMC4840931 | biostudies-literature
UnknownEffects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies.
Not available
S-EPMC5869871 | biostudies-literature
UnknownRandomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
Not available
S-EPMC5089161 | biostudies-literature
UnknownAdagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
Not available
S-EPMC9908297 | biostudies-literature
UnknownOpen-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies.
Not available
S-EPMC11295983 | biostudies-literature
UnknownPhase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.
Not available
S-EPMC9398147 | biostudies-literature
UnknownMyeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer.
Not available
S-EPMC11907075 | biostudies-literature
Sort   by:  
 Page size